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Our objective was to elucidate the effects of different HCV peptides on TH1 cytokine synthesis (interleukin 2(IL2),
gamma interferon (INFγ) and tumor necrosis factor α (TNF α)), in a proliferative response in a high risk population of
HCV seronegative aviremic Egyptian healthcare workers (HCW). We studied the TH1 cytokine response to different
HCV peptides among 47 HCW with and without evidence of HCV infection. Participants were classified according to
the proliferation index (PI) in a CFSE proliferation assay as an indicator of previous exposure to HCV. Cytokines were
analyzed using Luminex xMAP technology. Results showed that positive PI HCW produced a higher IL2 in response
to all HCV peptides except NS4, a higher IFNγ response to NS3 and NS4 and no difference in TNFα response when
compared to the negative PI HCWs. When compared to chronic HCV HCW, positive PI HCW showed no difference
in the IL2 response, a higher IFNγ response to NS4 and NS5 HCV peptides and a higher TNFα response to all
peptides. In conclusion the magnitude and type of cytokines produced in HCV infection is critical in determining
the outcome of infection. NS4 & NS5 HCV peptides induce a protective TH1 response in positive PI HCW
Keywords: CFSE, Proliferation assayBackground
Prospective studies of healthcare workers (HCW) after
occupational exposure have identified the average hepa-
titis C virus (HCV) transmission rate associated with
contaminated needle sticks to be 1.8% [1]. Kubitschke
et al. 2007 carried out a systematic review of 22 studies
reporting a total of 6956 injuries involving HCV-
contaminated needles and demonstrated seroconversion
rates ranging between 0% and 10.3%, with a mean of
0.75% with worldwide differences in HCV seroconver-
sion rates. This suggests that genetic factors might pro-
vide some level of natural resistance against HCV [2].
Little is known about the prevalence of HCV among
HCW in Egypt, where the highest worldwide prevalence
of HCV exists. In recent studies the prevalence of HCV
antibody in Egyptian HCW workers was found to range
from 11.2% to 16.6% [3,4] and HCV viraemia was found
to be 8%, but the prevalence was not significantly differ-
ent than that found among non-medical personnel.* Correspondence: monarafik@hotmail.com
1Ain Shams Faculty of Medicine Clinical Pathology Department, Abbassia
square, Cairo, Egypt
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reproduction in any medium, provided the orPrevious studies in Egypt concluded that the infections
were more likely to be community-acquired and not oc-
cupationally related but Rafik et. al [3] added that
workers in the dialysis unit and laboratory technicians
showed significantly higher prevalence than other job
groups in the same departments.
HCV-specific T-cell responses have been described in
studies of exposed HCV-seronegative individuals [2-5]
where these responses were found to be broad and asso-
ciated with risk factors for HCV exposure, suggesting
that they reflected true exposure to HCV in seronegative
persons. Evidence for the presence of a cellular immune
response was detected by a CFSE assay where a positive
proliferative response to different HCV peptides was
detected in 27/60 aviraemic seronegative Egyptian la-
boratory and blood bank HCW [6].
Conflicting results have been reported about the mag-
nitude, breadth, quality and duration of HCV specific
immune responses in different clinical settings of HCV
infection. Due to the difficulty in identifying persons
who successfully clear acute HCV; examination of im-
mune responses in large numbers of exposed but unin-
fected persons provides an alternate strategy ford. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Table 1 Demographic characteristics of HCWs





< 25 5 8.4%
25–40 43 71.7%






Blood Bank 15 25%
Job category
Worker 15 25%




Positive history 31 51.7%
Negative history 29 48.3%
Family history
Positive history 14 23.3%
Negative history 46 76.7%
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Our aim was thus to research one aspect of the protect-
ive HCV immune response in HCW, the TH1cytokine
response to different HCV peptides in a high risk popu-
lation of Egyptian HCW, to elucidate the effects of
different HCV peptides on cytokine synthesis in a prolif-
erative response. The hypothesis was that the type and
level of TH1 cytokines produced during their HCV ex-
posure may be a critical determinant of viral clearance
Material and methods
The study began with screening 240 of the staff working
in Ain shams University Hospitals (Internal Medicine
Hospital). The study sample was composed of different
categories of professionals. One hundred eighty seven
health care workers (personnel who either had direct
contact with patients or with potentially infectious clin-
ical specimens as blood and body fluids.) were enrolled
in the study and included 48 resident doctors, 77 nurses,
17 technicians and 45 workers. A control group was in-
cluded; consisting of 53 of the administrative employees
(secretaries, personnel management employees, account-
ing employees, etc.…) in the same hospital who had no
contact with patients, or with material used by them.
After written consent a detailed questionnaire was
obtained from each participant with special emphasis on
occupational risk factors for HCV which included dur-
ation of employment, exposure to needle stick injuries,
accidental splashes of blood or body fluids onto mucous
membranes and failure to adhere to essential infection
control procedures (gloves). All participants were ini-
tially tested for ALT level, and HCV-antibody carried
out by third-generation enzyme-linked immunosorbent
assay (ELISA) for serum anti-HCV antibodies. HCV
RNA detection was carried out by Real-time RT-PCR for
all participants:
The study showed that according to the occupation la-
boratory technicians had a greater prevalence of infec-
tion than other occupations (p < 0.01) in different
departments of the hospital.
Among the 187 HCWs included in the study, 67.9%
reported exposure to needle stick injuries, 56.7%
reported splashes of blood or body fluids to the eye or
mucous membranes, 82.4% handled body fluids as part
of their job description, 17.6% did not use gloves, 53.5%
used gloves and 28.9% used gloves intermittently. HCV
infection was statistically significantly associated with
failure to use gloves (p < 0.05).
After determining the HCV status of the previous sub-
jects, 60 were selected from the laboratory and blood
bank personnel since they had the greater prevalence of
infection than all other HCW and the highest exposure
to blood (Table 1). They included 60 HCWs (38 males
and 22 females) with a mean age of 36 ± 10 years whoworked at Ain Shams University laboratory and blood
bank. Only 10 of them were found to be viraemic (HCV
PCR + ve) and were HCV antibody + ve while all the
other were seronegative for HCV antibody and aviraemic
for HCV.
PBMCs from study subjects were isolated immediately
from fresh heparinized blood by Ficoll-Hypaque density gra-
dient centrifugation using standard techniques and immedi-
ately tested for antigen-specific cell proliferation and CFSE
assays [7]. Proliferation assays were performed without or
after 5, 6-carboxyfluorescein diacetate succinimidyl ester.
Freshly isolated cells were resuspended in PBS that
had been supplemented with 5% FCS (Eurobio), to a
final cell concentration of 1 million / ml. CFSE was
added at a concentration of 5 μM/μL (Molecular probes,
Invitrogen). After 10 min incubation, at 37°C, in the
dark cells were pelleted, washed extensively, and
resuspended in 1 ml of ice cold RPMI-1640 that had
been supplemented with 10% FCS, 1% HEPES, 0.2%
Gentamicin. CFSE labeled cells were then stimulated in
a 7-day culture with (PHA) (Sigma Aldrich) (10 μg /ml)
as a positive control and HCV peptides (core (aa 2–120),
nonstructural protein 3 (NS3) (1192–1457), nonstructural
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tein 5 (NS5) (aa 2054–2995core,) (Chiron) (4 μg /well) for
7 days in 10% CO2 at 37°C. Unstimulated cells with
medium only were used as negative controls.
On the seventh day GUAVA EASY cyte 4 color flow
cytometry was used to determine the percent of the par-
ent cells and the mean fluorescence intensity (MFI) of
the CFSE stained cells. The Proliferation index (P.I) was
calculated according to Lyons and Parish, 1994 [7]. P.I
was considered + ve if it was higher than the cut off
values calculated (= Mean P.I of positive Control group
x1 .68 standard deviation (SD) for each peptides used).
Cell culture supernatants from the peripheral blood
mononuclear cells (PBMCs) stimulated by HCV peptides
in the CFSE proliferation assay for 47 HCW were col-
lected and stored at −80°C until assayed. The personnel
included in this study were divided into two groups:
1) HCV double negative (HCWs)Table 2 Cytokine response to different HCV peptides in
studied groups (Kruskall Wallis)
Group Cytokine Median cytokine (pg/ml) p
HCV PEPTIDES
CORE NS3 NS4 NS5
Positive PI HCW IL2 16.855 36.18 17.405 20.18 0.209
IFN-γ 2.16 11.4 3.31 2.0 0.662
TNFα 60.2 66.4 75.8 117 0.012*
Negative PI HCW IL2 1.6 6.8 3.7 3.33 0.196
IFN-γ .83 1.36 0 0.83 0.588
TNFα 14.8 157.4 30.4 79.5 0.168
Chronic HCV HCW IL2 10.9 16.1 8.7 28.33 0.807
IFN-γ .065 0.35 0.28 0.175 0.583
TNFα 16.2 18.0 25. 8 20.3 0.989
p * ≤ 0.05 significant.(negative PCR & antibody) (Group I): This group
included 37 HCWs who had normal serum alanine
aminotransferase, serum aspartate aminotransferase,
and negative HCV antibody & were negative for HCV
RNA. According to the proliferation index (PI) in the
CFSE proliferation assay for the HCV peptides, group
1 HCW was further classified into 2 subgroups.
Group1a) Positive proliferation index (+ve P.I)
HCWs: Subjects whose cells showed a P.
I more than the cut off values of the PI
for the HCV specific peptides of the
chronic group in the CFSE assay (group
2) (27 samples were available).
Group1b) Negative proliferation index (−ve P.I)
HCWs: Subjects in group I whose cells
showed a P.I less than the cut off values
of the PI of HCVspecific peptides of the
chronic group in the CFSE assay (10
samples).
2) Chronic HCV HCWs (positive Control group):
(Double Positive: PCR & antibody for HCV)
(Group II)) which consisted of 10 HCW
HCV proteins used were derived from the HCV-
genotype 1 sequence and encoded core (aa 2–120),
nonstructural protein 3 (NS3) (1192–1457),
nonstructural protein 4 (NS4) (aa 1569–1931), and
nonstructural protein 5 (NS5) (aa 2054–2995).
TH1 Cytokine analysis
All cell culture supernatants were analyzed using
Luminex xMAP technology for IL2, IFNγ and TNFα.
Reagents were supplied by R&D diagnostics designed
for use with the Luminex100™, Analyzer manufactured
by Luminex Corporation. (R&D systems, Minneapolis,
United States of America).All protocols for this study were reviewed and ap-
proved by the Ain Shams Faculty of Medicine ethics
committee and all participants provided written in-
formed consent.Statistical analysis
IBM statistical package for social sciences (SPSS statis-
tics) (V. 19.0, IBM Corp., USA, 2010) was used for data
analysis. Data was expressed as median and percentiles
for quantitative non-parametric measures utilizing
Wilcoxon Rank Sum test, Ranked Spearman correlation
test and Kruskall Wallis testResults
Cytokine responses to HCV peptides produce a similar
pattern within each individual group
All of the HCV peptides, structural and nonstructural,
(Core, NS3, NS4 and NS5) studied produced a similar
IL2 and INF γ response with no significant difference
between them in each group. However in the positive PI
HCW the TNFα response was significantly higher than
the other studied groups (Table 2). Correlations between
the cytokines studied in response to the different HCV
peptides within each group were done and Spearman
correlation coefficient (Rs) is reported (Table 3).
In positive PI HCW both structural (core) and
nonstructural (NS3 and NS5) HCV peptides produced a
positive correlation between IL2 and INFγ while in the
negative HCW only nonstructural peptides (NS4 & NS5)
did. There was no correlation between IL2 and TNF
produced in response to HCV peptides in all studied
groups. There was a positive correlation between INFγ
and TNFα produced in response to core NS4 and NS5
in positive PI HCW and to NS3 in chronic HCV HCW.
Table 3 Correlation between cytokine responses to HCV Peptides within individual groups
Group INFγ & IL2 IL2 & TNFα TNFα & INFγ
HCV Peptide Rs p HCV Peptide Rs p HCV Peptide Rs p
1-a:Positive P.I HCWs: Core 0.514 0.014 Core 0.279 0.21 Core 0.447 0.028
NS3 0.51 0.024 NS3 −0.1 0.6 NS3 0.2 0.3
NS4 0.226 0.311 NS4 0.797 0.44 NS4 0.436 0.026
NS5 0.512 0.015 NS5 0.127 0.60 NS5 0.445 0.03
1-b: Negative P.I HCWs: Core 0.403 0.282 Core −0.53 0.14 Core −0.153 0.694
NS3 0.451 0.223 NS3 −0.6 0.1 NS3 −0.5 0.1
NS4 0.893 0.003 NS4 0.47 0.24 NS4 −0.035 0.924
NS5 0.72 0.029 NS5 0.644 0.06 NS5 0.338 0.339
2-Chronic HCV HCW Core −0.395 0.439 Core −0.6 0.28 Core −0.112 0.858
NS3 −0.894 0.041 NS3 −0.1 0.8 NS3 0.8 0.04
NS4 0.051 0.935 NS4 0.60 0.285 NS4 0.698 0.123
NS5 −0.213 0.686 NS5 −0.5 0.391 NS5 0.759 0.08
Spearman correlation coefficient (Rs) is reported.
Strong correlations (|Rs| ≥ 0.5) are indicated in bolded print; black indicates positive correlations; italics indicates negative correlations.
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between groups
There was no difference in IL2 response to all the HCV
peptides between positive HCW and the chronic HCV
HCWs group (Table 4) but there was a higher IL2 re-
sponse to all the HCV peptides except NS4 in compari-
son to the negative HCW Only the core peptide resulted
in a higher IL2 response in the chronic HCV HCW
compared to the negative PI HCW.
Regarding the IFNγ response in positive HCW only
NS4 and NS5 peptides resulted in a significantly stron-
ger IFNγ response compared to chronic HCV HCWs
and a higher response to NS3and NS4 peptides com-
pared to the negative HCW group (Table 5).
The IFN gamma response to NS4 in positive HCW is
significantly higher than in negative HCW whereas there
was no significant difference in the IL2 response to this
peptide. There was no correlation between both cyto-
kines in response to NS4 in positive HCW and there
was such a correlation in the negative HCW.
In this study NS3 peptide evoked the strongest INFγ










Median IL2 (pg/ml) Median
CORE 16.85 10.995 0.575 16.85
NS3 36.18 16.1 0.165 36.18
NS4 17.40 8.7 0.574 17.40
NS5 20.18 28..33 0.674 20.18
Significant difference (Wilson Rank Sum) (p ≤ 0.5) is indicated in bolded black print.different except in the positive HCW who were higher
than the negative HCW. The IL2 response to the NS3
peptide in the positive HCW was higher than that in the
negative HCW with the presence of a positive correl-
ation with IFN γ which could not be detected in the
negative HCW. The HCV NS3 peptide seems to stimu-
late a predominantly IL2 dependent INFγ production in
positive PI HCW.
The TNFα response to the different HCV peptides
showed no difference between positive and negative PI
HCW with a significantly higher response to all peptides
between positive PI HCW and chronic HCV HCW. NS3
and NS5 peptides produced a lower TNFα in chronic
HCV HCW than even the negative PI HCW (Table 6).
The NS4 and NS5 peptide results typically display a
type 1 TH cytokine profile in positive PI HCW which is
not true in chronic HCV HCW where they induce a
lower INFγ and TNFα response.
Discussion
Clearance of HCV-RNA may not necessarily correlate









IL2 (pg/ml) Median IL2 (pg/ml)
1.6 0.006 10.995 1.6 0.009
6.82 0.013 16.11 6.82 0.461
3.69 0.071 8.7 3.69 0.305
3.33 0.046 28.33 3.33 0.093

















Median INFγ (pg/ml) Median INFγ (pg/ml) Median INFγ (pg/ml)
CORE 2.16 0.065 0.103 2.16 0.83 0.119 0.065 0.83 0.376
NS3 11.4 0.35 0.055 11.4 1.36 0.031 0.35 1.36 1
NS4 3.31 0.28 0.026 3.31 0 0.004 0.28 0 0.811
NS5 2 0.2 0.041 2 1 0.135 0.2 1 0.295
Significant difference (Wilson Rank Sum) (p ≤ 0.5) is indicated in bolded black print.
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after occupational exposure to HCV [8]. Studies indicate
that selected high-risk subjects can mount an effective
immune response against HCV infection in the absence
of antibody production and that they may have a higher
likelihood of viral clearance in that setting [9-14].
The immunodominance hierarchies within HLA-A2
-restricted HCV-specific CD8+ T cell responses were re-
cently studied to determine if they are linked to naive-
precursor frequency [15]. Precursor frequencies to
Core132, NS3 1406 and NS5B 2594 specific epitopes
were conserved across the healthy donors although they
varied significantly between epitopes suggesting that a
clear hierarchy of naive HCV-specific CD8 + T cell pre-
cursor frequencies exists in healthy donors [15]. The
NS3 1406 epitope had the highest naive-precursor fre-
quency in healthy donors and the most frequently
targeted epitope in chronic HCV-infected patients, both
ex vivo and after in vitro stimulation, whereas the core
132 epitope was rarely targeted in most studies [16-19].
For assessing human antiviral T cell responses the func-
tions quantified simultaneously include up regulation of
IFN γ and IL2 [20-22]. In this study of all the HCV pep-
tides studied NS3 peptide (1192 to 1457) evoked the
highest IL2 response in both positive and negative HCW
whereas the core peptide produced the lowest IL2 re-
sponse. The difference in the IL2 induced was signifi-
cantly higher in positive HCW than the negative HCW
for all peptides except NS4. The most predominant IL2










Median TNFα (pg/ml) Median
CORE 60.18 16.17 0.026 60.18
NS3 66.4 18 0.002 66.4
NS4 75.8 25.8 0.002 75.8
NS5 117 20.3 0.000 117
Significant difference (Wilson Rank Sum) (p ≤ 0.5) is indicated in bolded black print.and the lowest was by the NS4 peptide but the only sig-
nificantly higher IL2 response compared to the negative
HCW was that obtained by the core peptides. When
compared to the positive HCW, all the HCV peptides in
chronic HCV HCW produced lower levels of IL2 but
with no significant difference.
IL2 plays a critical role in the regulation of Th1 and
Th2 responses and impacts INFγ production [23]. INFγ
production in chronic HCV HCW was not significantly
different from the negative PI HCW for all peptides
tested. At the same time positive PI HCW showed a sig-
nificantly higher INFγ in response to NS4 and NS5 than
the chronic HCV HCW and a significantly higher INFγ
in response to NS3 and NS4 than the negative HCW.
The failure to produce INFγ, in response to HCV NS4
peptide in chronically HCV-infected patients has been
previously documented [24].
IL2 cytokine secretion in response to a panel of re-
combinant HCV antigens in patients with acute HCV
has been studied previously and showed that patients
with self-limited disease had a significant secretion of
IL2 [25] and those who developed chronicity had signifi-
cantly lower IL-2 [26] and INFγ production than those
cases who recovered [27,28]. The previously described
’stunned’ T cell phenotype in chronic HCV infection
[20,29] was seen in this study for almost all of the
nonstructural peptides (NS4 and NS5) with near signifi-
cance for NS3 (p = 0.055). Resolved HCV infection is as-
sociated with T-cells responses with higher IFNγ









TNFα (pg/ml) Median TNFα (pg/ml)
14.81 0.063 16.17 14.81 0.841
157.4 0.678 18 157.4 0.007
30.4 0.374 25.8 30.4 0.277
79.5 0.112 20.3 79.5 0.017
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solved infection was to the relatively small core protein,
and these responses were not significantly different from
persons with chronic infection [35]. Perrella et al. (2009)
[36] searched for evidence of hepatitis C virus-specific
interferon gamma-positive T cells in health care workers
in an infectious disease department. They found that
levels of HCV-specific IFN-gamma-positive cells were
higher in the HCWs compared with the infected patients
and healthy blood donors. The investigators concluded
that a clinically silent persistent exposure to HCV,
through some as-yet undetermined mechanism, may in-
duce a virus-specific IFN-gamma-producing CD8 (+) T-
cell response in healthy aviremic HCWs. This finding
suggests that possible unapparent parenteral routes may
stimulate host defenses with no evidence of hepatitis.
The observed pattern of a vigorous CTL response and
relatively weaker humoral response predicting disease
resolution suggests that HCV persistence also relates to
the pattern of cytokine release [14]. Persistence may re-
late to a relative insensitivity of HCV to antiviral cyto-
kines such as TNFα and IFNγ [10,18],since viral
clearance was associated with a greater magnitude and
broader specificity of IFNγ and IL2 responses [37]. Fi-
nally the frequent and low levels of HCV viremia may
have been controlled by innate immune responses with-
out a strong adaptive immunity [8].
Cross-reactivity to other commonly encountered anti-
gens is an alternative explanation for the T cell responses
found However, a range of viral proteins elicited re-
sponses, including the structural proteins core as well as
the nonstructural proteins, with no single antigen stand-
ing out as immunodominant. These T cell responses
suggest that our subjects were indeed exposed to HCV.
Cell-mediated immune (CMI) responses to hepatitis C
virus (HCV) antigens in adults without seroconversion
or viraemia are biomarkers for prior transient infection
[14]. It may be stipulated that these CMI-positive HCV
seronegative subjects may have had a transient very mild
infection, possibly associated with low-dose exposure to
the virus, which was cleared. Conventional mechanisms
for sustaining T cell memory are likely to be involved,
including cytokine-driven homeostatic proliferation [38].
NS4 and NS5 protein antigens represent immuno-
genic, possibly protective, regions of the HCV genome
in this group of positive PI HCW. The protective nature
of NS5 peptide has been previously reported in unin-
fected siblings of HCV chronically infected children [14].
The HCV-specific cytokine responses observed in
aviremic, seronegative HCW were qualitatively and
quantitatively different from those observed in chronic
HCV HCW. Our results show that T-helper 1 type
cytokines are produced following stimulation with
nonstructural antigens (NS4, and NS5) by positive PIHCW (who had resolved HCV infection) similar to the
results demonstrated by others [39,40].
Abdulwahab et al. (2012) demonstrated a strong and
broad HCV-specific IFN-γ response without detectable
viremia or seroconversion in more than half (55.8%) of
Egyptian HCW, with both CD4+ and CD4− T cells pro-
ducing IFN-γ (the highest responses were to NS3 &
NS5a). They did not find a significant correlation be-
tween the strength and breadth of the HCV-specific
CMI in these seronegative aviremic subjects and their
demographic, clinical, or laboratory data [41]. The latest
research on Egyptian HCW conducted at Ain Shams
University Hospital, Cairo included HCWs reporting oc-
cupational blood exposure who had neither anti-HCV
antibodies (anti-HCV) nor HCV RNA, and were ex-
posed to a HCV RNA positive patient. They were en-
rolled in a 6-month prospective cohort with follow-up
visits at weeks 2, 4, 8, 12 and 24. During follow-up, anti-
HCV, HCV RNA and ALT were tested. Of 73 HCWs ex-
posed to HCV RNA from index patients, nine presented
transient viremia, the majority of which occurred within
the first two weeks after exposure. None of the workers
presented seroconversion or elevation of ALT. The au-
thors concluded that HCWs of a general University hos-
pital in Cairo were exposed to a highly viremic patient
population and they experienced frequent occupational
blood exposures, particularly in early stages of training.
These exposures resulted in transient viremic episodes
without established infection [42].
The cytokine response against viral protein antigens
shown in our study was elicited when PBMCs were
cocultured with recombinant HCV antigens without the
addition of any particular cytokines in vitro for differen-
tiation into effector cells. Immunological memory in
these HCW may have been established upon a prior ex-
posure to the virus and a subsequent exposure to the
antigen was capable of inducing a prompt HCV-specific
effector function ex-vivo, possibly providing antiviral
protection. The maintenance of these effector T cell re-
sponses may be sustained by repeated low-level exposure
to HCV and stimulation of memory cells.Conclusion
In conclusion, we present our observation that a sub-
stantial percentage of HCV-seronegative aviremic HCW
who are potentially exposed to the virus by virtue of
their occupation develop a protective TH1 cytokine pro-
file which may have protected them from persistent in-
fection and probably protects against subsequent
exposure. An increased understanding of the cytokine
environment early in HCV infection is important for the
development of novel therapeutics to facilitate viral
clearance.
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